{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:33:57Z","timestamp":1757781237007},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00595-012-0131-y","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T04:54:37Z","timestamp":1328072077000},"page":"429-433","source":"Crossref","is-referenced-by-count":2,"title":["The calcitonin levels can sometimes mislead parathyroid surgeons in patients with chronic kidney disease and renal hyperparathyroidism: report of a case"],"prefix":"10.1007","volume":"43","author":[{"given":"Ralph","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna E.","family":"Schaumburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"issue":"2","key":"131_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0039-6109(16)44189-7","volume":"67","author":"A Sitges-Serra","year":"1987","unstructured":"Sitges-Serra A, Caralps-Riera A. Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment. Surg Clin N Am. 1987;67(2):359\u201377.","journal-title":"Surg Clin N Am"},{"issue":"5","key":"131_CR2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1445-2197.2003.t01-1-02620.x","volume":"73","author":"A Aly","year":"2003","unstructured":"Aly A, Douglas M. Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg. 2003;73(5):284\u20138.","journal-title":"ANZ J Surg"},{"issue":"4","key":"131_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/145749690409300407","volume":"93","author":"K Schlosser","year":"2004","unstructured":"Schlosser K, Zielke A, Rothmund M. Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg. 2004;93(4):288\u201397.","journal-title":"Scand J Surg"},{"issue":"10","key":"131_CR4","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archsurg.134.10.1108","volume":"134","author":"FF Chou","year":"1999","unstructured":"Chou FF, Lee CH, Chen JB. General weakness as an indication for parathyroid surgery in patients with secondary hyperparathyroidism. Arch Surg. 1999;134(10):1108\u201311.","journal-title":"Arch Surg"},{"issue":"13","key":"131_CR5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM196809262791308","volume":"279","author":"SG Massry","year":"1968","unstructured":"Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med. 1968;279(13):697\u2013700.","journal-title":"N Engl J Med"},{"issue":"4","key":"131_CR6","first-page":"299","volume":"1","author":"PF Hirsch","year":"2001","unstructured":"Hirsch PF, Lester GE, Talmage RV. Calcitonin, an enigmatic hormone: does it have a function? J Musculoskelet Neuronal Interact. 2001;1(4):299\u2013305.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"3","key":"131_CR7","first-page":"3","volume":"52","author":"DM Findlay","year":"2006","unstructured":"Findlay DM. Regulation of cell growth mediated by the calcitonin receptor. Cell Mol Biol (Noisy-le-grand). 2006;52(3):3\u20138.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"2","key":"131_CR8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92(2):450\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"131_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787\u2013803.","journal-title":"Eur J Endocrinol"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MPA.0b013e3182015f5d","volume":"40","author":"R Schneider","year":"2010","unstructured":"Schneider R, Waldmann J, Swaid Z, Ramaswamy A, Fendrich V, Bartsch DK, Schlosser K. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas. 2010;40:213\u201321.","journal-title":"Pancreas"},{"issue":"8","key":"131_CR11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0029-1231083","volume":"118","author":"R Schneider","year":"2010","unstructured":"Schneider R, Heverhagen AE, Moll R, Bartsch DK, Schlosser K. Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors: a report of two cases. Exp Clin Endocrinol Diabetes. 2010;118(8):520\u20133.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"131_CR12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00268-007-9187-z","volume":"31","author":"K Schlosser","year":"2007","unstructured":"Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernandez ED. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg. 2007;31(10):1947\u201353.","journal-title":"World J Surg"},{"issue":"1","key":"131_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/CCO.0b013e32831ba0b3","volume":"21","author":"S Roman","year":"2009","unstructured":"Roman S, Mehta P, Sosa JA. Medullary thyroid cancer: early detection and novel treatments. Curr Opin Oncol. 2009;21(1):5\u201310.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"131_CR14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2265.2003.01681.x","volume":"58","author":"LM Demers","year":"2003","unstructured":"Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf). 2003;58(2):138\u201340.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"131_CR15","unstructured":"Leboulleux S, Baudin E, Travagli JP, Schlumberger M. Medullary Thyroid Carcinom: Secretory Products. http:\/\/www.medscape.com\/viewarticle\/489038_5 . Internet. 2011."},{"issue":"9","key":"131_CR16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/clinchem\/48.9.1505","volume":"48","author":"G Vitale","year":"2002","unstructured":"Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del PS, Abbruzzese A, Lupoli G. Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clin Chem. 2002;48(9):1505\u201310.","journal-title":"Clin Chem"},{"issue":"1","key":"131_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","volume":"13","author":"Z Baloch","year":"2003","unstructured":"Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3\u2013126.","journal-title":"Thyroid"},{"issue":"5","key":"131_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0025-6196(12)65441-X","volume":"62","author":"H Gharib","year":"1987","unstructured":"Gharib H, Kao PC, Heath H III. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests. Mayo Clin Proc. 1987;62(5):373\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"131_CR19","first-page":"29","volume":"119","author":"M Verdy","year":"1978","unstructured":"Verdy M, Cholette JP, Cantin J, Lacroix A, Sturtridge WC. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. Can Med Assoc J. 1978;119(1):29\u201335.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"131_CR20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2003-031983","volume":"89","author":"SP Hodak","year":"2004","unstructured":"Hodak SP, Burman KD. The calcitonin conundrum\u2013is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab. 2004;89(2):511\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"131_CR21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-142-11-200506070-00011","volume":"142","author":"MR Castro","year":"2005","unstructured":"Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med. 2005;142(11):926\u201331.","journal-title":"Ann Intern Med"},{"issue":"2","key":"131_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.82.2.335","volume":"82","author":"PK Horvit","year":"1997","unstructured":"Horvit PK, Gagel RF. The goitrous patient with an elevated serum calcitonin\u2013what to do? J Clin Endocrinol Metab. 1997;82(2):335\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"131_CR23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/thy.2007.0413","volume":"18","author":"TS Wang","year":"2008","unstructured":"Wang TS, Ocal IT, Sosa JA, Cox H, Roman S. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid. 2008;18(8):889\u201394.","journal-title":"Thyroid"},{"issue":"10","key":"131_CR24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/thy.2000.10.919","volume":"10","author":"AH Redding","year":"2000","unstructured":"Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid. 2000;10(10):919\u201322.","journal-title":"Thyroid"},{"issue":"6","key":"131_CR25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/105072504323150813","volume":"14","author":"M Bockhorn","year":"2004","unstructured":"Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid. 2004;14(6):468\u201370.","journal-title":"Thyroid"},{"issue":"8","key":"131_CR26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-002-6613-0","volume":"26","author":"M Iacobone","year":"2002","unstructured":"Iacobone M, Niccoli-Sire P, Sebag F, De MC, Henry JF. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg. 2002;26(8):886\u201390.","journal-title":"World J Surg"},{"issue":"6","key":"131_CR27","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1067\/msy.2099.102268","volume":"126","author":"C Scheuba","year":"1999","unstructured":"Scheuba C, Kaserer K, Weinhausl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery. 1999;126(6):1089\u201395.","journal-title":"Surgery"},{"issue":"1","key":"131_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2004-815727","volume":"112","author":"W Karges","year":"2004","unstructured":"Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hufner M, Niederle B, Brabant G. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes. 2004;112(1):52\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"131_CR29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/thy.1999.9.943","volume":"9","author":"H Kotzmann","year":"1999","unstructured":"Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, Soregi G, Niederle B, Vierhapper H. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid. 1999;9(9):943\u20137.","journal-title":"Thyroid"},{"issue":"6","key":"131_CR30","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1210\/jc.2007-2496","volume":"93","author":"K Cheung","year":"2008","unstructured":"Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab. 2008;93(6):2173\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 2","key":"131_CR31","first-page":"F593","volume":"254","author":"RE Simmons","year":"1988","unstructured":"Simmons RE, Hjelle JT, Mahoney C, Deftos LJ, Lisker W, Kato P, Rabkin R. Renal metabolism of calcitonin. Am J Physiol. 1988;254(4 Pt 2):F593\u2013600.","journal-title":"Am J Physiol"},{"issue":"11","key":"131_CR32","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/sj.ki.5001888","volume":"70","author":"KA Borchhardt","year":"2006","unstructured":"Borchhardt KA, Heinzl H, Gessl A, Horl WH, Kaserer K, Sunder-Plassmann G. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int. 2006;70(11):2014\u201320.","journal-title":"Kidney Int"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-012-0131-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-012-0131-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T15:03:24Z","timestamp":1593615804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-012-0131-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1007\/s00595-012-0131-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}